204 related articles for article (PubMed ID: 33353364)
1. A narrative review of targeted therapies in meningioma.
Kim L
Chin Clin Oncol; 2020 Dec; 9(6):76. PubMed ID: 33353364
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy, hormonal therapy, and immunotherapy for recurrent meningiomas.
Sioka C; Kyritsis AP
J Neurooncol; 2009 Mar; 92(1):1-6. PubMed ID: 19023520
[TBL] [Abstract][Full Text] [Related]
3. Advances in meningioma therapy.
Norden AD; Drappatz J; Wen PY
Curr Neurol Neurosci Rep; 2009 May; 9(3):231-40. PubMed ID: 19348712
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
[TBL] [Abstract][Full Text] [Related]
5. [Meningioma: management of the most common brain tumour].
Hundsberger T; Surbeck W; Hader C; Putora PM; Conen K; Roelcke U
Praxis (Bern 1994); 2016 Apr; 105(8):445-51. PubMed ID: 27078728
[TBL] [Abstract][Full Text] [Related]
6. Malignant meningiomas.
Fountain DM; Young AMH; Santarius T
Handb Clin Neurol; 2020; 170():245-250. PubMed ID: 32586496
[TBL] [Abstract][Full Text] [Related]
7. Advances in the systemic therapy for recurrent meningiomas and the challenges ahead.
Li Y; Drappatz J
Expert Rev Neurother; 2023; 23(11):995-1004. PubMed ID: 37695700
[TBL] [Abstract][Full Text] [Related]
8. Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.
Raheja A; Colman H; Palmer CA; Couldwell WT
J Neurosurg; 2017 Nov; 127(5):965-970. PubMed ID: 27935362
[TBL] [Abstract][Full Text] [Related]
9. Meningioma.
Fathi AR; Roelcke U
Curr Neurol Neurosci Rep; 2013 Apr; 13(4):337. PubMed ID: 23463172
[TBL] [Abstract][Full Text] [Related]
10. Medical therapies for meningiomas.
Wen PY; Quant E; Drappatz J; Beroukhim R; Norden AD
J Neurooncol; 2010 Sep; 99(3):365-78. PubMed ID: 20820875
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy and targeted therapies for meningiomas: what is the evidence?
Graillon T; Tabouret E; Chinot O
Curr Opin Neurol; 2021 Dec; 34(6):857-867. PubMed ID: 34629433
[TBL] [Abstract][Full Text] [Related]
12. A narrative review of targeted therapy in meningioma, pituitary adenoma, and craniopharyngioma of the skull base.
Martinez NL; Khanna O; Farrell CJ
Chin Clin Oncol; 2020 Dec; 9(6):75. PubMed ID: 32819111
[TBL] [Abstract][Full Text] [Related]
13. Multimodality Therapy of Patients with Refractory Meningiomas.
Ahmad H; Schiff D
Curr Treat Options Oncol; 2019 May; 20(6):50. PubMed ID: 31073797
[TBL] [Abstract][Full Text] [Related]
14. Biology and Treatment of Meningiomas: A Reappraisal.
McFaline-Figueroa JR; Kaley TJ; Dunn IF; Bi WL
Hematol Oncol Clin North Am; 2022 Feb; 36(1):133-146. PubMed ID: 34801160
[TBL] [Abstract][Full Text] [Related]
15. Current experimental therapies for atypical and malignant meningiomas.
Corona AM; Di L; Shah AH; Crespo R; Eichberg DG; Lu VM; Luther EM; Komotar RJ; Ivan ME
J Neurooncol; 2021 Jun; 153(2):203-210. PubMed ID: 33950341
[TBL] [Abstract][Full Text] [Related]
16. Medical treatment of recurrent meningiomas.
Chamberlain MC; Barnholtz-Sloan JS
Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
[TBL] [Abstract][Full Text] [Related]
17. Determining the role of adjuvant radiotherapy in the management of meningioma: a Surveillance, Epidemiology, and End Results analysis.
Reddy AK; Ryoo JS; Denyer S; McGuire LS; Mehta AI
Neurosurg Focus; 2019 Jun; 46(6):E3. PubMed ID: 31153148
[TBL] [Abstract][Full Text] [Related]
18. A Practical Overview on the Molecular Biology of Meningioma.
Delgado-López PD; Cubo-Delgado E; González-Bernal JJ; Martín-Alonso J
Curr Neurol Neurosci Rep; 2020 Nov; 20(12):62. PubMed ID: 33136206
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma.
Shih KC; Chowdhary S; Rosenblatt P; Weir AB; Shepard GC; Williams JT; Shastry M; Burris HA; Hainsworth JD
J Neurooncol; 2016 Sep; 129(2):281-8. PubMed ID: 27311730
[TBL] [Abstract][Full Text] [Related]
20. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
